"Stephanie brings tremendous experience in understanding of laboratory operations which are critical as Allegro approaches commercialization. We are thrilled to have her as a key member of the senior management team," said Josh Phillips, Allegro board member and General Partner with Catalyst Health Ventures.
"We are proud to be making such excellent additions to the Allegro team," said Dan Rippy, President & CEO of Allegro Diagnostics. "Steve will provide superb guidance and perspective to the board as we seek to build the leading molecular diagnostics franchise in lung cancer. Stephanie brings essential talents to Allegro in the areas of laboratory operations, management, and quality systems, which will be integral to the commercial success of our products."
About Lung Cancer
Lung cancer is the leading cause of cancer death in the industrialized world, responsible for more than 1.3 million deaths per year worldwide. In the U.S., lung cancer kills more people than colon, breast, prostate, and ovarian cancers combined. According
Copyright©2009 Vocus, Inc.
All rights reserved